Navigating the healthcare system with a BRCA1/2 pathogenic variant: What do patients value?
Tina Karimaghaie1, Emily M Webster2, Sarah R Levi2
1Genetics and Personalized Cancer Prevention Program, Weill Cornell Medicine / 1305 York Avenue, 3rd Floor, New York, NY 10021, USA.
Purpose:
BRCA1/2 pathogenic variants (PVs) confer elevated lifetime risk of malignancies, including breast, ovarian, prostate, and pancreatic cancer. Navigating care is complex; patient-reported preventive, psychosocial, and logistical needs remain poorly understood. We evaluated patient perspectives through a survey disseminated via advocacy networks.
Methods:
Individuals with self-reported BRCA1/2 PVs completed an anonymous 20-question survey on care preferences. The survey was distributed via email through advocacy and support networks. Descriptive statistics summarized demographics, clinical characteristics, and responses. Open-ended responses were analyzed using thematic analysis.
Results:
Thirty individuals visited the survey website with 90% (27) completion. Median age was 45 years (IQR, 38-68); 23 (85%) identified as non-Hispanic White, 3 (11%) Hispanic White, and 1 (4%) non-Hispanic Black. All participants identified as female. Participants valued a single clinician/institution managing BRCA1/2 PV-related needs (26, 96%) and same-day appointments (25, 93%). Participants preferred BRCA1/2 PV expertise among specialists managing ovarian and breast cancer screening (27, 100%), menopause management (25, 100%), and risk-reducing breast/gynecologic surgery (22, 96%). Twenty-one (78%) were interested in care at a hereditary cancer center. Qualitative analysis reinforced the value of physician expertise in clinical and psychological BRCA1/2 PV management and a centralized model of care that reduces lifelong logistical burden.
Conclusion:
Individuals with self-reported BRCA1/2 PVs preferred streamlined care through a single clinician/center, with expertise in cancer screening, risk-reducing surgery, and menopause management. A dedicated hereditary cancer program integrating clinical management, psychosocial support, and streamlined logistics may help improve care satisfaction, adherence, and confidence. These findings provide patient-centered guidance for optimizing care delivery in this high-risk population.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Patient-centered Care
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...


